To verify the interaction between FGF2 and FGFR2 to the progression of T-ALL, FGF2-shRNA vector was constructed and the knockdown efficiency in MSCs was high (Fig. 4G). This evidence concerns the gene FGF2 and acute lymphoblastic leukemia.